Detalhe da pesquisa
1.
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol.
Infect Dis Ther
; 13(1): 237-250, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38102448